Abstract
To examine the effects of 1-(2-pyrimidinyl)-piperazine (1-PP), a buspirone metabolite, on bladder function in vivo. Micturition reflexes in the rat were evaluated in two models of bladder function; a constant infusion model employing 0.5% acetic acid and an isovolumic model. In the constant infusion model, 1-PP (0.14-1.32 mg/kg) dose-dependently and significantly decreased the number of bladder contractions measured during a 30 min recording period, with little effect on the pressure developed during each contraction. 1-PP is an alpha2-adrenergic receptor antagonist. The alpha2 antagonists BRL44408 (alpha2A vs. alpha2B selective; 0.3 and 1 mg/kg), imiloxan (alpha(2B) vs. alpha2A selective; 1 mg/kg), and yohimbine (non-subtype selective; 1 mg/kg; but not 0.3 mg/kg) also significantly reduced the number of contractions. Vehicle was without effect. In the isovolumic model, 1-PP (0.03-1.0 mg/kg) produced a dose-dependent and significant reduction in the number of bladder contractions recorded during a 15 min assessment period, with the maximum effect observed at 0.3 mg/kg. 1-PP had little effect on blood pressure; the only effect was observed at the highest dose (1 mg/kg) where it produced a transient 17% decrease in pressure. Crom...Continue Reading
References
Dec 1, 1992·Japanese Journal of Pharmacology·H KontaniT Sakai
Mar 1, 1990·British Journal of Pharmacology·A D MichelR L Whiting
Apr 1, 1990·The Journal of Urology·A MalmgrenC Sjögren
Sep 22, 1989·European Journal of Pharmacology·P YoungM A Cawthorne
Feb 1, 1988·The Journal of Urology·N YoshimuraS Takaori
Mar 1, 1983·British Journal of Pharmacology·T L BerridgeI F Tulloch
Nov 1, 1996·The Journal of Urology·O IshizukaK E Andersson
May 30, 1997·European Journal of Pharmacology·L NilvebrantB Sparf
Dec 31, 1997·Journal of Neurochemistry·A GobertM J Millan
Sep 28, 1998·Naunyn-Schmiedeberg's Archives of Pharmacology·A Newman-TancrediM J Millan
Sep 28, 1999·European Journal of Pharmacology·Y Mateo, J J Meana
May 3, 2000·BJU International·M S Jeong, J G Lee
Sep 16, 2000·European Journal of Pharmacology·H SeshitaS Ueda
Dec 16, 2000·Expert Opinion on Investigational Drugs·A J Wein
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·W C de Groat, N Yoshimura
Jun 18, 2002·European Journal of Pharmacology·Begoña Fernández-Pastor, J Javier Meana
Nov 20, 2002·The Journal of Pharmacology and Experimental Therapeutics·Klaas P ZuideveldMeindert Danhof
Citations
Oct 20, 2006·Acta Pharmacologica Sinica·Shi-ping MaLi-hua Duan
Mar 21, 2008·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·K S ThorneloeM T Nelson
Apr 5, 2016·European Journal of Pharmacology·Takaomi ShimokawaTokihito Yukimura
Dec 7, 2016·Behavioural Pharmacology·Manato KotaniKazuhito Ikeda
Mar 2, 2021·Neural Regeneration Research·Long MaXiao-Jian Gu
Nov 12, 2017·Pharmacology, Biochemistry, and Behavior·A Newman-TancrediM A Varney